MetaADEDB 2.0 @ LMMD
Moclobemide
(YHXISWVBGDMDLQ-UHFFFAOYSA-N)
Structure
SMILES
O=C(c1ccc(cc1)Cl)NCCN1CCOCC1
Type(s)
Approved; Investigational
ATC code(s)
N06AG02
Molecular Formula:
C13H17ClN2O2
Molecular Weight:
268.739
Log P:
1.7308
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
1
TPSA:
41.57
CAS Number(s):
71320-77-9
Synonym(s)
1.
Moclobemide
2.
Apo-Moclobemide
3.
Arima
4.
Aurorex
5.
Aurorix
6.
Chem mart Moclobemide
7.
DBL Moclobemide
8.
Deprenorm
9.
Feraken
10.
GenRX Moclobemide
11.
Healthsense Moclobemide
12.
Manerix
13.
Moclamine
14.
Moclix
15.
Moclobamide
16.
Moclobemid AZU
17.
Moclobemid Stada
18.
Moclobemid von ct
19.
Moclobemid-1A Pharma
20.
Moclobemid-Puren
21.
Moclobemid-ratiopharm
22.
Moclobeta
23.
Moclodura
24.
Moclonorm
25.
Novo-Moclobemide
26.
Nu-Moclobemide
27.
PMS-Moclobemide
28.
Rimoc
29.
Ro 11-1163
30.
Ro-11-1163
31.
Terry White Chemists Moclobemide
32.
AZU, Moclobemid
33.
Apo Moclobemide
34.
Moclobemid 1A Pharma
35.
Moclobemid Puren
36.
Moclobemid ratiopharm
37.
Moclobemid1A Pharma
38.
Moclobemide, Chem mart
39.
Moclobemide, DBL
40.
Moclobemide, GenRX
41.
Moclobemide, Healthsense
42.
Novo Moclobemide
43.
NovoMoclobemide
44.
Nu Moclobemide
45.
NuMoclobemide
46.
PMS Moclobemide
47.
Ro 11 1163
48.
Stada, Moclobemid
49.
von ct, Moclobemid
External Link(s)
MeSHD020912
PubChem Compound4235
BindingDB15613
ChEBI83531
CHEMBLCHEMBL86304
DrugBankDB01171
DrugCentral1825
IUPHAR/BPS Guide to PHARMACOLOGY7428
KEGGdr:D02561
Therapeutic Target DatabaseD01ZSO
ZINC19606670
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainSIDER
2Abdominal bloatingSIDER
3Abdominal discomfortCanada Vigilance: 1Canada Vigilance
4AbuseOFFSIDES
5AgitationCanada Vigilance: 1Canada Vigilance
SIDER
6Alanine Aminotransferase IncreasedOFFSIDES
7Alcohol abuseOFFSIDES
8Allergic skin reactionSIDER
9AlopeciaCanada Vigilance: 2Canada Vigilance
10AmnesiaCanada Vigilance: 3Canada Vigilance
11Anal candidiasisOFFSIDES
12AngerCanada Vigilance: 1Canada Vigilance
13Angina PectorisSIDER
14Anorectal discomfortSIDER
15AnorexiaOFFSIDES
16Anticholinergic SyndromeOFFSIDES
17Anxiety stateSIDER
18AnxietyCanada Vigilance: 3Canada Vigilance
SIDER
19ApathyOFFSIDES
SIDER
20ArthritisOFFSIDES
21AstheniaSIDER
22AsthmaOFFSIDES
23AtaxiaOFFSIDES
24Bipolar DisorderCanada Vigilance: 111473503CTD
Canada Vigilance
25Blood glucose abnormalOFFSIDES
26Blood pH decreasedOFFSIDES
27Blood prolactin increasedOFFSIDES
28Blurred visionOFFSIDES
29BradycardiaSIDER
30Breast cancer stage IIOFFSIDES
31BronchospasmCanada Vigilance: 1Canada Vigilance
32Candidiasis of vaginaOFFSIDES
33Cerebrovascular accidentCanada Vigilance: 1Canada Vigilance
34Chest PainSIDER
35ClonusOFFSIDES
36ConfabulationOFFSIDES
37ConjunctivitisSIDER
38ConstipationSIDER
39Cutaneous CandidiasisOFFSIDES
40Depressive disorder

View details

CTD
41DermatitisSIDER
42DiarrheaOFFSIDES
43DiscomfortSIDER
44DisorientationCanada Vigilance: 1Canada Vigilance
SIDER
45Disseminated Intravascular CoagulationOFFSIDES
46DizzinessCanada Vigilance: 2Canada Vigilance
SIDER
47DrowsinessOFFSIDES
SIDER
48Drug Overdose19131198CTD
49Drug abuserOFFSIDES
50Drug ineffectiveCanada Vigilance: 6Canada Vigilance
51Drug level increasedCanada Vigilance: 1Canada Vigilance
52Drug screen positiveOFFSIDES
53Drug toxicityOFFSIDES
54Dry skinSIDER
55DysarthriaSIDER
56DysgeusiaOFFSIDES
SIDER
57DyspepsiaSIDER
58DysuriaSIDER
59Epigastric discomfortSIDER
60EpistaxisOFFSIDES
61Euphoric moodOFFSIDES
62Eye painCanada Vigilance: 1Canada Vigilance
63FasciitisOFFSIDES
64FatigueOFFSIDES
SIDER
65Feeling ColdSIDER
66Feeling abnormalSIDER
67Flat affectSIDER
68FlatulenceSIDER
69FlushingSIDER
70Fullness abdominalSIDER
71GastritisSIDER
72Gastrointestinal PainSIDER
73GingivitisSIDER
74Hallucinations16025422CTD
75HeadacheCanada Vigilance: 2Canada Vigilance
SIDER
76HeartburnSIDER
77Hepatic congestionOFFSIDES
78HepatitisCanada Vigilance: 1Canada Vigilance
79HyperreflexiaOFFSIDES
80Hypotension7496658CTD
SIDER
81Inappropriate schedule of drug administrationOFFSIDES
82Increased agitationSIDER
83Intentional self-injuryOFFSIDES
84LethargyCanada Vigilance: 2Canada Vigilance
85Long QT Syndrome15958107CTD
86MalaiseSIDER
87Malignant neoplasm progressionOFFSIDES
88Memory impairmentCanada Vigilance: 1Canada Vigilance
89Menstrual cycle prolongedSIDER
90Mental disorders16856516CTD
91MetrorrhagiaSIDER
92Multiple drug overdoseOFFSIDES
93Multiple drug overdose intentionalOFFSIDES
94Musculoskeletal discomfortSIDER
95MyalgiaCanada Vigilance: 1Canada Vigilance
SIDER
96NauseaCanada Vigilance: 2Canada Vigilance
OFFSIDES
SIDER
97NervousnessSIDER
98OverdoseOFFSIDES
99PalpitationsSIDER
100ParanoiaCanada Vigilance: 1Canada Vigilance
101Patellofemoral Pain SyndromeOFFSIDES
102Poisoning15958107CTD
103PolyuriaSIDER
104Potentiating drug interactionOFFSIDES
105Pre-EclampsiaOFFSIDES
106Product prescribing errorCanada Vigilance: 1Canada Vigilance
107Product substitution issueCanada Vigilance: 1Canada Vigilance
108Progesterone receptor assayOFFSIDES
109PruritusSIDER
110Pulmonary congestionOFFSIDES
111Rectal tenesmusSIDER
112Risus sardonicusOFFSIDES
113Serotonin Syndrome

View details

CTD
114ShockSIDER
115Sinus bradycardiaOFFSIDES
116Sleep Initiation and Maintenance Disorders17168253CTD
117Small cell lung cancer extensive stageOFFSIDES
118SomnolenceCanada Vigilance: 2Canada Vigilance
SIDER
119StomatitisSIDER
120Suicide attemptCanada Vigilance: 1Canada Vigilance
121SweatingSIDER
122Symptom recurrenceCanada Vigilance: 2Canada Vigilance
123SyncopeSIDER
124TachycardiaSIDER
125TensionSIDER
126TinnitusCanada Vigilance: 1Canada Vigilance
SIDER
127TremorCanada Vigilance: 3Canada Vigilance
SIDER
128Urine output increasedSIDER
129UrticariaSIDER
130Visual ImpairmentCanada Vigilance: 1Canada Vigilance
SIDER
131Visual disturbanceSIDER
132VomitingCanada Vigilance: 1Canada Vigilance
SIDER
133colonoscopyOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.